HCW Share Price

HCW Share Price

NASDAQ: HCWB | Micro Cap | Healthcare
$0.70
+$0.70 (--%) Last updated on 21 Nov, 2026 | 02:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

HCW Stock Performance

Open
$0.70
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.70 - $0.70
Year Range
$0.25 - $5.45
Volume
200
Average Traded
$0.70

HCW Share Price Chart

Line chart of the HCW price trend over the selected period. The price rose overall, ranging from 0.70 to 0.70, ending at 0.70.
$0.70$0.70
L
Show Current Price
H

HCW Stock Fundamentals & Key Indicators

Market Cap
$1.47M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.19
Revenue (TTM)
$50.00M
Return On Equity (TTM)
-334.12%
Profit Margin
-44600.00%
Debt to Equity
1.00
Quarterly Earnings Growth YoY
-71.18%

HCW Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.03$6.54$0.14$0.06
Net Profit-$3.47$1.98-$15.37-$5.94
Net Profit Margin-11566.67%30.28%-10978.57%-9900.00%
Income ChangeN/A157.06%-876.26%61.35%

HCW Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$6.72$2.84$2.57$0.05
Net Profit-$14.90-$24.99-$30.02-$22.30
Net Profit Margin-221.73%-879.93%-1168.09%-44600.00%
Income ChangeN/A-67.72%-20.13%25.72%

HCW Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets22.2424.5422.1112.74
Current Assets2.285.76.434.07
Total Assets24.5230.2428.5146.81
Non Current Liabilities0.697.386.36.42
Current Liabilities21.0629.638.752.96
Total Liabilities21.7637.0115.059.38
Shareholders' Equity2.76-6.7713.4637.43

HCW Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-13.39-14.23-22.51-10.39
Investing0.0-0.263.814.71
Financing10.6715.57-0.016.27

Corporate Actions

Split
Ex-date: 30 Jun 2026

Split
Ex-date: 11 Apr 2025

About HCW

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

HCW Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.14
$0.70
-36.85%
Oct 2026
$1.71
$1.11
-39.18%
Sep 2026
$3.46
$1.82
-41.69%
Aug 2026
$3.95
$3.13
-4.86%
Jul 2026
$4.58
$3.29
-34.98%
Jun 2026
$2.03
$5.06
+153.00%
May 2026
$0.45
$2.00
+330.11%
Apr 2026
$0.33
$0.47
+34.78%
Mar 2026
$0.54
$0.34
-37.61%
Feb 2026
$1.14
$0.55
-50.84%
Jan 2026
$0.98
$1.13
+13.64%
Dec 2025
$2.07
$0.99
-52.86%

HCW Share Price FAQs